BioCatalyst

SGIOF — SHIONOGI & CO LTD catalysts

2 verified catalyst event(s) for SHIONOGI & CO LTD (ticker SGIOF). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-12-30 — A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12-30
in 3mo
ESTIMATED
 READOUT
A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncy
Phase 2 · Respiratory Syncytial Virus Infections
 SGIOF SHIONOGI & CO LTD S-337395 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-31
in 3mo
ESTIMATED
 READOUT
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apn
Phase 2 · Sleep Apnea
 SGIOF SHIONOGI & CO LTD Sivopixant, Acetazolamide, SASS-001 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.